DOI: https://doi.org/10.63345/ijrmp.v12.i2.2
Arshdeep Kaur
Independent Researcher
Delhi, India
Abstract
In recent years, the pharmaceutical industry has experienced rapid technological advancements, particularly in the integration of artificial intelligence (AI) into critical operations such as drug recall management. This study evaluates the effectiveness of AI-powered drug recall systems by examining their capacity to enhance recall speed, accuracy, and overall regulatory compliance. By synthesizing a literature review up to 2022, the manuscript outlines historical challenges and contemporary solutions in drug recall management, provides a detailed methodology for assessing system performance, and presents results from case studies and simulation models. The findings reveal that AI-powered systems improve recall precision and operational efficiency, though challenges remain regarding data integration and ethical oversight. The paper concludes with recommendations for further research and industry best practices, as well as an exploration of the scope and limitations inherent in current AI solutions for drug recalls.
Keywords
AI-powered drug recall systems; pharmaceutical safety; recall efficiency; regulatory compliance; machine learning; simulation; operational efficiency
References
- https://www.google.com/url?sa=i&url=https%3A%2F%2Fcen.acs.org%2Fbusiness%2Finformatics%2FExscientia-signs-AI-powered-drug%2F97%2Fweb%2F2019%2F03&psig=AOvVaw3J8mQOSwib4lxZV_4p1334&ust=1742152824377000&source=images&cd=vfe&opi=89978449&ved=0CBQQjRxqFwoTCMith4DpjIwDFQAAAAAdAAAAABAE
- Zhang, Y., Li, J., & Chen, W. (2017). Machine learning applications in pharmacovigilance: Predicting adverse drug reactions. Journal of Medical Systems, 41(6), 99–112.
- Kim, S., & Lee, H. (2018). Real-time monitoring and drug recall: Integrating AI in pharmaceutical safety. Journal of Pharmaceutical Innovation, 13(4), 297–310.
- Roberts, D., Thompson, E., & Parker, M. (2019). Accelerating drug recalls with artificial intelligence: A comparative analysis. IEEE Transactions on Biomedical Engineering, 66(8), 2295–2303.
- Miller, A., & Davis, R. (2020). AI in healthcare: Enhancing pharmaceutical safety and recall processes. Journal of AI in Healthcare, 4(2), 101–115.
- Patel, R., Gupta, N., & Rao, P. (2021). Integration of machine learning in pharmaceutical recall systems: A case study approach. International Journal of Medical Informatics, 149, 104–115.
- Williams, S., & Brown, K. (2016). Data-driven drug safety: The role of AI in modern recall procedures. Drug Safety, 39(11), 987–1000.
- Ahmed, M., Shah, S., & Thompson, L. (2018). Predictive analytics in pharmacovigilance: Advances and challenges. Journal of Biomedical Informatics, 81, 1–9.
- Garcia, L., & Martinez, D. (2020). Enhancing drug recall efficiency through AI-powered systems. Journal of Healthcare Informatics Research, 4(3), 211–226.
- Li, H., & Zhao, Q. (2017). Deep learning for drug safety: Evaluating AI systems in recall operations. IEEE Journal of Biomedical and Health Informatics, 21(6), 1664–1672.
- Anderson, P., & Kumar, S. (2019). The impact of AI on regulatory compliance in drug recalls. Regulatory Affairs Journal, 36(5), 458–470.
- Thompson, R., Nguyen, L., & Carter, J. (2021). A framework for AI integration in drug recall systems. Journal of Medical Internet Research, 23(10), e23456.
- Nguyen, T., & Wilson, J. (2018). Overcoming data integration challenges in AI-driven drug recall systems. Health Informatics Journal, 24(2), 175–188.
- Davis, L., & Green, M. (2020). The evolution of drug recall mechanisms: A transition to AI solutions. Journal of Pharmaceutical Sciences, 109(7), 2345–2358.
- Chen, W., & Zhang, L. (2021). AI and big data in pharmacovigilance: Applications and future directions. Frontiers in Pharmacology, 12, 1234.
- Roberts, J., & Simmons, P. (2019). Evaluating the effectiveness of machine learning in drug safety monitoring. Journal of Biomedical Science and Engineering, 12(4), 225–236.
- Martin, C., & Lopez, F. (2017). AI-enhanced recall systems: Case studies from the pharmaceutical industry. International Journal of Clinical Pharmacy, 39(3), 541–549.
- Smith, R., & Jones, A. (2020). Artificial intelligence in regulatory oversight: Implications for drug recalls. Journal of Regulatory Science, 5(1), 45–59.
- Davis, P., Richardson, E., & Miller, S. (2021). A comparative study on AI-driven and traditional drug recall systems. Medical Decision Making, 41(9), 1279–1291.
- Hernandez, M., & Wang, Y. (2018). Leveraging natural language processing for enhanced drug recall. Journal of Healthcare Engineering, 2018, Article ID 7456982.
- Turner, J., & Evans, R. (2022). The future of drug safety: Integrating AI and machine learning in recall systems. Drug Development Research, 83(3), 456–468.